News
-
Silver Spruce Resources, Inc. Announces New Chief Financial Officer
-
Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
-
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
-
Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
-
Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
-
dK Calls on PANDION AG Bondholders to Join Forces
-
Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
-
Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
-
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
-
Form 8.3 - The Vanguard Group, Inc.: Senior plc
-
GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
-
GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
-
Number of shares and voting rights - July 2026 (In French only)
-
BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
-
Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026